VB4-845
Term · Oncology and biomedicine · MLC-T-ONC-009191
A substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium.
| Identifier | MLC-T-ONC-009191 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | anti-EpCAM-Pseudomonas-exotoxin fusion protein; Proxinium |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009191",
"term": "VB4-845",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium.",
"expansions": [
"anti-EpCAM-Pseudomonas-exotoxin fusion protein",
"Proxinium"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vb4-845/"
}
Record 17,148 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.